News and Resources

Choose an area of interest:

Eosinophilic Asthma Epileptic Encephalopathy Company News
09.17.19

Knopp Biosciences Reports Data Demonstrating Restoration of Function by KB-3061 in Cellular Model of Gene Variants Causing KCNQ2 Epileptic Encephalopathy

Discover this News
09.13.19

The Re-Emergence of Kv7 Drug Discovery

Discover this News
05.24.19

Targeting Kv7.2/7.3 Activators for the Treatment of KCNQ2-NEE

Discover this News
05.24.19

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference

Discover this News
05.15.19

Knopp Biosciences to Present Data on its Potassium Channel Activator Program at 2019 Antiepileptic Drug and Device Trials XV Conference

Discover this News
01.03.19

Knopp Biosciences Enters Research Collaboration with Baylor College of Medicine to Develop New Treatments for KCNQ2 Neonatal Encephalopathy

Discover this News
09.05.18

Knopp Biosciences Announces Year 3 Renewal Of NIH Blueprint Grant Award For Advancing KCNQ2 Activators In Rare Neonatal Epilepsy

Discover this News
10.23.17

Knopp Biosciences Announces Renewal of NIH Blueprint Grant Award for Advancing KCNQ2 Modulators in Epilepsy

Discover this News
1 2